Trial record 1 of 1 for:    NCT00744861
Previous Study | Return to List | Next Study

Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery (EXO-SPINE)

This study has been terminated.
(Terminated following interim analysis)
Sponsor:
Information provided by (Responsible Party):
Bioventus LLC
ClinicalTrials.gov Identifier:
NCT00744861
First received: August 29, 2008
Last updated: July 23, 2013
Last verified: July 2013
  Purpose

The purpose of this study is to determine whether using active low intensity pulsed ultrasound as adjunct therapy following single level posterior instrumented lumbar surgery increases the posterolateral success rate when compared to inactive (placebo) therapy.


Condition Intervention
Lumbar Degenerative Disc Disease
Device: Low Intensity Pulsed Ultrasound
Device: Sham

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: EXO-SPINE: A Prospective, Multi-center, Double-blind, Randomized, Placebo Controlled Pivotal Study of Ultrasound as Adjunctive Therapy for Increasing Posterolateral Fusion Success Following Single Level Posterior Instrumented Lumbar Surgery

Further study details as provided by Bioventus LLC:

Primary Outcome Measures:
  • Posterolateral fusion success at the treated level [ Time Frame: 6 months and 12 months post treatment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To evaluate the effect(s) of the investigational treatment on pain/disability status [ Time Frame: 12 months post treatment ] [ Designated as safety issue: No ]
  • To evaluate the effect(s) of the investigational treatment on general health status [ Time Frame: 6 month and 12 month post treatment ] [ Designated as safety issue: No ]

Enrollment: 310
Study Start Date: September 2008
Study Completion Date: June 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Low Intensity Pulsed Ultrasound
Low Intensity Pulsed Ultrasound
Device: Low Intensity Pulsed Ultrasound
Sham Comparator: Sham
Sham (inactive) low intensity pulsed ultrasound device
Device: Sham

  Eligibility

Ages Eligible for Study:   18 Years to 81 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The subject has a documented diagnosis of degenerative disc disease with up to Grade I spondylolisthesis at the target level
  • Requires spinal fusion of a single level disc space (L2 to S1) with the use of local bone graft.
  • Requires a posterolateral fusion procedure with or without an interbody fusion procedure using a posterior approach
  • The subject has failed non-operative treatment lasting at least 6 months.

Exclusion Criteria:

  • Requires spinal fusion at more than one lumbar level.
  • Is pregnant, is lactating or plans to become pregnant before discontinuation of study treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00744861

  Hide Study Locations
Locations
United States, California
La Jolla, California, United States, 92037
Oakland, California, United States, 94609
San Francisco, California, United States, 94134
United States, Florida
Boynton Beach, Florida, United States
Clearwater, Florida, United States
United States, Georgia
Savannah, Georgia, United States, 31405
United States, Illinois
Chicago, Illinois, United States
Peoria, Illinois, United States
United States, Indiana
Indianapolis, Indiana, United States
United States, Kansas
Kansas City, Kansas, United States
Merriam, Kansas, United States
United States, Massachusetts
Boston, Massachusetts, United States
United States, Michigan
Kalamazoo, Michigan, United States, 49007
Southfield, Michigan, United States
United States, New Jersey
Egg Harbor Township, New Jersey, United States
Newark, New Jersey, United States, 07103
United States, New York
New York, New York, United States, 10016
United States, North Carolina
Charlotte, North Carolina, United States
Greenville, North Carolina, United States
United States, Oklahoma
Oklahoma City, Oklahoma, United States, 73109
United States, Pennsylvania
Philadelphia, Pennsylvania, United States, 19140
United States, Tennessee
Bristol, Tennessee, United States, 37620
United States, Texas
Houston, Texas, United States, 77043
The Woodlands, Texas, United States, 77380
United States, Utah
Salt Lake City, Utah, United States
United States, Wisconsin
Madison, Wisconsin, United States
Sponsors and Collaborators
Bioventus LLC
Investigators
Principal Investigator: Jeffrey Fischgrund, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Bioventus LLC
ClinicalTrials.gov Identifier: NCT00744861     History of Changes
Other Study ID Numbers: EX-SPINE0907
Study First Received: August 29, 2008
Last Updated: July 23, 2013
Health Authority: United States: Food and Drug Administration

Keywords provided by Bioventus LLC:
Lumbar Fusion
exospine
Exo-Spine

Additional relevant MeSH terms:
Intervertebral Disk Degeneration
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on July 28, 2014